nicotinamide mononucleotide has been researched along with Cognitive Dysfunction in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 5 (62.50) | 2.80 |
| Authors | Studies |
|---|---|
| Dilxat, T; Lin, J; Liu, X; Qiu, T; Shi, Q | 1 |
| Li, J; Lu, J; Nadeeshani, H; Ying, T; Zhang, B | 1 |
| Campbell, JM | 1 |
| Guan, X; Jiang, G; Pang, T; Tang, L; Xie, L; Zhao, N; Zhu, X | 1 |
| Badalzadeh, R; Farokhi-Sisakht, F; Hosseini, L; Khabbaz, A; Mahmoudi, J; Sadigh-Eteghad, S | 1 |
| Bae, MG; Baur, JA; Brogren, D; Cho, CH; Choi, J; Corujo-Ramirez, A; Hawse, JR; Hou, X; Jang, MH; Kirkeby, LA; Oliveros, A; Rashid, MA; Tang, JJ; Weroha, SJ; Yoo, KH | 1 |
| Balasubramanian, P; Bari, F; Csipo, T; Csiszar, A; Farkas, E; Kiss, T; Lipecz, A; Reglodi, D; Tarantini, S; Ungvari, Z; Valcarcel-Ares, MN; Yabluchanskiy, A; Zhang, XA | 1 |
| Hu, X; Sakurai, T; Takata, T; Wang, X; Yang, Y | 1 |
2 review(s) available for nicotinamide mononucleotide and Cognitive Dysfunction
| Article | Year |
|---|---|
Nicotinamide mononucleotide (NMN) as an anti-aging health product - Promises and safety concerns.
Topics: Aged; Aging; Cognitive Dysfunction; Humans; Longevity; NAD; Nicotinamide Mononucleotide | 2022 |
Supplementation with NAD
Topics: Animals; Cognitive Dysfunction; Dietary Supplements; Humans; NAD; Niacin; Niacinamide; Nicotinamide Mononucleotide | 2022 |
6 other study(ies) available for nicotinamide mononucleotide and Cognitive Dysfunction
| Article | Year |
|---|---|
The combination of nicotinamide mononucleotide and lycopene prevents cognitive impairment and attenuates oxidative damage in D-galactose induced aging models via Keap1-Nrf2 signaling.
Topics: Aging; Animals; Cognitive Dysfunction; Drug Therapy, Combination; Galactose; Gene Expression Regulation; Kelch-Like ECH-Associated Protein 1; Lycopene; Male; Morris Water Maze Test; NF-E2-Related Factor 2; Nicotinamide Mononucleotide; Oxidative Stress; PC12 Cells; Rats; Signal Transduction; Spatial Learning; Treatment Outcome | 2022 |
The Combination of Citicoline and Nicotinamide Mononucleotide Induces Neurite Outgrowth and Mitigates Vascular Cognitive Impairment via SIRT1/CREB Pathway.
Topics: Animals; Cognitive Dysfunction; Cytidine Diphosphate Choline; Dementia, Vascular; NAD; Neuroinflammatory Diseases; Neuronal Outgrowth; Nicotinamide Mononucleotide; Rats; Sirtuin 1 | 2023 |
Nicotinamide Mononucleotide and Melatonin Alleviate Aging-induced Cognitive Impairment via Modulation of Mitochondrial Function and Apoptosis in the Prefrontal Cortex and Hippocampus.
Topics: Adenosine Triphosphate; Aging; Animals; Apoptosis; Cognitive Dysfunction; Drug Synergism; Hippocampus; Male; Maze Learning; Melatonin; Membrane Potential, Mitochondrial; Mitochondria; Nicotinamide Mononucleotide; Prefrontal Cortex; Rats; Reactive Oxygen Species; Recognition, Psychology | 2019 |
Nicotinamide Mononucleotide Prevents Cisplatin-Induced Cognitive Impairments.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Proliferation; Cisplatin; Cognitive Dysfunction; Female; Humans; Mice; Mice, SCID; Neuroprotective Agents; Nicotinamide Mononucleotide; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2021 |
Nicotinamide mononucleotide (NMN) treatment attenuates oxidative stress and rescues angiogenic capacity in aged cerebromicrovascular endothelial cells: a potential mechanism for the prevention of vascular cognitive impairment.
Topics: Aging; Animals; Brain; Cell Movement; Cell Proliferation; Cognitive Dysfunction; Endothelial Cells; Hydrogen Peroxide; Microvessels; Neovascularization, Physiologic; Nicotinamide Mononucleotide; Oxidative Stress; Rats, Inbred BN; Rats, Inbred F344 | 2019 |
Nicotinamide mononucleotide protects against β-amyloid oligomer-induced cognitive impairment and neuronal death.
Topics: Adenosine Triphosphate; Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Death; Cognitive Dysfunction; Disease Models, Animal; Hippocampus; Long-Term Potentiation; Male; Maze Learning; Memory; Mitochondria; NAD; Neurons; Neuroprotective Agents; Nicotinamide Mononucleotide; Peptide Fragments; Rats; Rats, Wistar; Reactive Oxygen Species; Superoxides; Tissue Culture Techniques | 2016 |